Journal of Clinical Endocrinology & Metabolism

The Journal of Clinical Endocrinology & Metabolism (JCEM), published by the Endocrine Society, is a premier peer-reviewed periodical dedicated to the advancement of clinical endocrinology. With an ISSN of 0021-972X and a 2026 Journal Impact Factor of 5.4000, the journal holds a distinguished Q1 ranking in its category, reflecting its high citation impact and authoritative standing within the field. JCEM’s scope encompasses the full spectrum of endocrine and metabolic disorders, including diabetes, thyroid disease, bone and mineral metabolism, reproductive endocrinology, pituitary and adrenal disorders, neuroendocrinology, and lipid metabolism. The journal prioritizes original research that translates basic science into clinical practice, featuring rigorous clinical trials, cohort studies, and translational investigations. Beyond primary research, JCEM publishes authoritative reviews, meta-analyses, clinical practice guidelines, and insightful commentaries that synthesize emerging evidence for the medical community. Its target audience comprises clinical endocrinologists, metabolic disease specialists, endocrine researchers, and healthcare professionals engaged in patient care and clinical decision-making. Notable features include a hybrid open-access model, allowing authors to publish their work as open access under a Creative Commons license, while subscription-based access ensures broad dissemination. The journal is known for its stringent peer-review process and rapid publication of high-impact findings that directly influence clinical guidelines and therapeutic strategies. As a flagship title of the Endocrine Society, JCEM remains an essential resource for those seeking cutting-edge, evidence-based knowledge in clinical endocrinology and metabolism.